On 15 May 2009, orphan designation (EU/3/09/641) was granted by the European Commission to Atlantic Healthcare Limited, United Kingdom, for alicaforsen for the treatment of pouchitis.
In July 2013, Atlantic Healthcare Limited changed name to Atlantic Healthcare plc.
The sponsorship was transferred to Atlantic Pharmaceuticals (Holdings) Ltd, United Kingdom, in November 2017.
The sponsorship was transferred to Atlantic Healthcare Europe B.V., the Netherlands, in April 2019.
|Disease / condition||
Treatment of pouchitis
|Date of decision||
|Orphan decision number||
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
- European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
- Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;